The Newest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
Epidermal development issue receptor (EGFR) is a tyrosine kinase receptor concerned in homeostatic regulation of regular cells and carcinogenesis of epithelial malignancies. With speedy improvement of the precision drugs period, a collection of recent therapies concentrating on EGFR are underway.
- 4 EGFR monoclonal antibody medication (cetuximab, panitumumab, nimotuzumab, and necitumumab) are already on the market, and a dozen different EGFR monoclonal antibodies are in medical trials.
- Right here, we comprehensively evaluation the newly recognized organic properties and anti-tumor mechanisms of EGFR monoclonal antibodies.
- We summarize not too long ago accomplished and ongoing medical trials of the basic and new EGFR monoclonal antibodies.
- Extra importantly, in response to our new commonplace, we re-classify the advanced evolving tumor cell resistance mechanisms, together with these involving exosomes, non-coding RNA and the tumor microenvironment, in opposition to EGFR monoclonal antibodies.
- Lastly, we analyzed the constraints of EGFR monoclonal antibody remedy, and mentioned the present methods overcoming EGFR associated drug resistance.
- This evaluation will assist us higher perceive the most recent battles between EGFR monoclonal antibodies and resistant tumor cells, and the long run instructions to develop anti-tumor EGFR monoclonal antibodies with sturdy results.
A high-throughput neutralizing antibody assay for COVID-19 prognosis and vaccine analysis
Virus neutralization stays the gold commonplace for figuring out antibody efficacy. Subsequently, a high-throughput assay to measure SARS-CoV-2 neutralizing antibodies is urgently wanted for COVID-19 serodiagnosis, convalescent plasma remedy, and vaccine improvement.
Right here, we report on a fluorescence-based SARS-CoV-2 neutralization assay that detects SARS-CoV-2 neutralizing antibodies in COVID-19 affected person specimens and yields comparable outcomes to plaque discount neutralizing assay, the gold commonplace of serological testing.
The fluorescence-based neutralization assay is restricted to measure COVID-19 neutralizing antibodies with out cross reacting with affected person specimens with different viral, bacterial, or parasitic infections. Collectively, our method gives a speedy platform that may be scaled to display folks for antibody safety from COVID-19, a key parameter needed to securely reopen native communities.
controlpeptidecomprimary-antibodies
Recombinant Human LEC |
|||
| MBS7608806-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human LEC |
|||
| MBS7608806-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Recombinant Human LEC (CCL16) |
|||
| MBS4159662-0025mg | MyBiosource | 0.025mg | EUR 385 |
Recombinant Human LEC (CCL16) |
|||
| MBS4159662-1mg | MyBiosource | 1(mg) | EUR 4600 |
Recombinant Human LEC (CCL16) |
|||
| MBS4159662-5x1mg | MyBiosource | 5x1mg | EUR 20445 |
Human LEC (CCL16) Recombinant |
|||
| MBS553045-0005mg | MyBiosource | 0.005mg | EUR 165 |
Human LEC (CCL16) Recombinant |
|||
| MBS553045-0025mg | MyBiosource | 0.025mg | EUR 245 |
Recombinant Human LEC (CCL16) |
|||
| Z100325 | ABM | 25 µg | EUR 235 |
|
Description: CCL16 is a CC chemokine that specifically attracts lymphocytes, dendritic cells, and monocytes; increases their adhesive properties and has myelosuppressive activity. It is constitutively expressed in liver and is increased by interleukin 10 (IL-10) in activated monocytes. CCL16 is present in human plasma suggesting that it may be active outside hepatic tissue. CCR1, CCR2, CCR5, and CCR8 are the functional receptors of this chemokine. |
|||
Recombinant Human LEC (CCL16) |
|||
| Z100329 | ABM | 1.0 mg | EUR 3900 |
|
Description: CCL16 is a CC chemokine that specifically attracts lymphocytes, dendritic cells, and monocytes; increases their adhesive properties and has myelosuppressive activity. It is constitutively expressed in liver and is increased by interleukin 10 (IL-10) in activated monocytes. CCL16 is present in human plasma suggesting that it may be active outside hepatic tissue. CCR1, CCR2, CCR5, and CCR8 are the functional receptors of this chemokine. |
|||
Human LEC/CCL16 Antibody Pair Set |
|||
| ABPR-ZB293 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
|
Description: Quantitative determination of Human LEC/CCL16 |
|||
Anti-Human LEC/NCC-4 Antibody |
|||
| 102-P51G | ReliaTech | 100 µg | EUR 245.7 |
|
Description: LEC or NCC-4 is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
|||
Anti-Human LEC Goat Polyclonal Antibody |
|||
| TA328365 | Origene Technologies GmbH | 100 µg | Ask for price |
Human LEC/NCC-4 (CCL16) |
|||
| MBS692056-0005mg | MyBiosource | 0.005mg | EUR 300 |
Human LEC/NCC-4 (CCL16) |
|||
| MBS692056-002mg | MyBiosource | 0.02mg | EUR 450 |
Human LEC/NCC-4 (CCL16) |
|||
| MBS692056-5x002mg | MyBiosource | 5x0.02mg | EUR 1725 |
Recombinant Human LEC/CCL16 protein |
|||
| CD01396-5ug | Jiaxing Korain Biotech Ltd (BT Labs) | 5ug | EUR 176 |
|
Description: Human CCL16, also called Liver-expressed chemokine (LEC), Monotactin-1 (MTN-1), IL-10-inducible chemokine and so on, is expressed by the CCL16 gene located on the chromosome 17 in humans. The gene encodes a 120 a.a. residue precursor protein with a 23 a.a. residue predicted signal peptide that is cleaved to generate a 97 a.a. residue mature protein. The protein is secreted by the liver, thymus, spleen cells and showing chemotactic activity for lymphocytes and monocytes but it is distantly related to other CC chemokines, exhibiting less than 30 % sequence identity. CCL16 is highly induced by IL-10, IFN-γ and bacterial lipopolysaccharide in monmcytes and signal through CCR1, CCR2, CCR5, and CCR8. |
|||
Recombinant Human LEC (CCL16) Protein |
|||
| PROTO15467-1 | BosterBio | 20ug | EUR 380.4 |
|
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
|||
LEC/NCC-4 Human Recombinant |
|||
| rAP-0241 | Angio Proteomie | Inquiry | Ask for price |
Human LEC Recombinant Protein Lyophilized |
|||
| IHULECRLY5UG | Innovative research | each | EUR 341 |
|
Description: Human LEC Recombinant Protein Lyophilized |
|||
Human LEC Recombinant Protein Lyophilized |
|||
| MBS8432637-INQUIRE | MyBiosource | INQUIRE | Ask for price |
LEC antibody |
|||
| 70R-LG003 | Fitzgerald | 50 ug | EUR 312 |
|
Description: Affinity purified Goat polyclonal LEC antibody |
|||
LEC antibody |
|||
| 10R-L115A | Fitzgerald | 500 ug | EUR 240 |
|
Description: Mouse monoclonal LEC antibody |
|||
LEC Antibody |
|||
| CSB-PA916043XA01DOA-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Arabidopsis thaliana LEC protein |
|||
LEC Antibody |
|||
| CSB-PA916043XA01DOA-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Arabidopsis thaliana LEC protein |
|||
LEC antibody |
|||
| MBS532318-05mg | MyBiosource | 0.5mg | EUR 370 |
LEC antibody |
|||
| MBS532318-5x05mg | MyBiosource | 5x0.5mg | EUR 1525 |
LEC antibody |
|||
| MBS535708-005mg | MyBiosource | 0.05mg | EUR 465 |
LEC antibody |
|||
| MBS535708-5x005mg | MyBiosource | 5x0.05mg | EUR 1945 |
Biotinylated Anti-Human LEC Goat Polyclonal Antibody |
|||
| TA328364 | Origene Technologies GmbH | 50 µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| 7-01792 | CHI Scientific | 5µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| 7-01793 | CHI Scientific | 20µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| 7-01794 | CHI Scientific | 1mg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| HECCP-1601 | Cyagen | 5ug | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| MBS143272-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| MBS143272-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| MBS143272-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| MBS143272-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-14] |
|||
| LEC-14-100ug | Biologicals | 100 ug | EUR 141.79 |
|
Description: Identify and measure human LEC. Marker for inflammatory processes. |
|||
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-14] |
|||
| LEC-14-1mg | Biologicals | 1 mg | EUR 897.6 |
|
Description: Identify and measure human LEC. Marker for inflammatory processes. |
|||
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-14] |
|||
| LEC-14-500ug | Biologicals | 500 ug | EUR 479.6 |
|
Description: Identify and measure human LEC. Marker for inflammatory processes. |
|||
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-57] |
|||
| LEC-57-100ug | Biologicals | 100 ug | EUR 141.79 |
|
Description: Identify and measure human LEC. Marker for inflammatory processes. |
|||
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-57] |
|||
| LEC-57-1mg | Biologicals | 1 mg | EUR 897.6 |
|
Description: Identify and measure human LEC. Marker for inflammatory processes. |
|||
LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-57] |
|||
| LEC-57-500ug | Biologicals | 500 ug | EUR 479.6 |
|
Description: Identify and measure human LEC. Marker for inflammatory processes. |
|||
lec-7 Antibody |
|||
| CSB-PA600640XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans lec-7 protein |
|||
lec-7 Antibody |
|||
| CSB-PA600640XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans lec-7 protein |
|||
lec-3 Antibody |
|||
| CSB-PA601014XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans lec-3 protein |
|||
lec-3 Antibody |
|||
| CSB-PA601014XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans lec-3 protein |
|||
lec-1 Antibody |
|||
| CSB-PA330605XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans lec-1 protein |
|||
lec-1 Antibody |
|||
| CSB-PA330605XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans lec-1 protein |
|||
lec-8 Antibody |
|||
| CSB-PA222370XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans lec-8 protein |
|||
lec-8 Antibody |
|||
| CSB-PA222370XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans lec-8 protein |
|||
LEC/CCL16 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118261-15Plates | MyBiosource | 15Plates | EUR 600 |
LEC/CCL16 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118261-5Plates | MyBiosource | 5Plates | EUR 345 |
LEC/CCL16 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118261-5x15Plates | MyBiosource | 5x15Plates | EUR 2755 |
HCC-4, LEC, NCC-4, CCL16, human |
|||
| RC315-27 | Bio Basic | 5ug | EUR 125.26 |
Human LEC/NCC-4 (CCL16) Recombinant Protein |
|||
| 100-060 | ReliaTech | 20 µg | EUR 196.35 |
|
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
|||
Human LEC/NCC-4 (CCL16) Recombinant Protein |
|||
| 100-060S | ReliaTech | 5 µg | EUR 92.4 |
|
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
|||
LEC (CCL16) (NM_004590) Human Over-expression Lysate |
|||
| E45H18931-2 | EnoGene | 20 ug | EUR 395 |
LEC (CCL16) (NM_004590) Human Over-expression Lysate |
|||
| LS006360 | BosterBio | 100ug | EUR 628 |
|
Description: Transient overexpression lysate of chemokine (C-C motif) ligand 16 (CCL16) |
|||
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
| E45H52205E1-50 | EnoGene | 50 ug | EUR 670.31 |
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
| MBS8120314-005mg | MyBiosource | 0.05mg | EUR 340 |
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
| MBS8120314-1mg | MyBiosource | 1mg | EUR 2530 |
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
| MBS8120314-5x1mg | MyBiosource | 5x1mg | EUR 11240 |
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
| MBS8120315-005mg | MyBiosource | 0.05mg | EUR 340 |
LEC/CCL16 Protein, Human, Recombinant (His Tag) |
|||
| MBS8120315-5x005mg | MyBiosource | 5x0.05mg | EUR 1380 |
CCL16 LEC/NCC-4 Human Recombinant Protein |
|||
| PROTO15467 | BosterBio | Regular: 20ug | EUR 250 |
|
Description: CCL16 Human Recombinant produced in E. coli is a non-glycosylated, Polypeptide chain containing 97 amino acids and having a molecular mass of 11.2 kDa. The CCL16 is purified by proprietary chromatographic techniques. |
|||
LEC, NCC-4, Human (Liver-Expressed Chemokine) |
|||
| MBS635010-0005mg | MyBiosource | 0.005mg | EUR 340 |
LEC, NCC-4, Human (Liver-Expressed Chemokine) |
|||
| MBS635010-002mg | MyBiosource | 0.02mg | EUR 490 |
LEC, NCC-4, Human (Liver-Expressed Chemokine) |
|||
| MBS635010-5x002mg | MyBiosource | 5x0.02mg | EUR 2055 |
LEC Chemokine(LEC66) Antibody |
|||
| BNC800066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF680 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC800066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF680 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC800067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC800067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC810066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC810066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC810067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC810067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC680066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC680066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC680067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC680067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Drug Tolerant Anti-drug Antibody Assay for Infliximab Remedy in Medical Follow Identifies Constructive Instances Earlier
A subgroup of sufferers handled with infliximab lose response to the remedy and one purpose for that is the event of anti-drug antibodies (ADA). If used optimally, measuring drug and ADA degree might result in a extra customized and environment friendly remedy regime, and allow identification of ADA-positive sufferers earlier than the underlying illness flares or allergic reactions happen.
With the usage of a drug-tolerant ADA assay which might detect ADA no matter drug ranges within the pattern, we decided the affect of ADA on remedy failure to infliximab. The goals of this examine had been to estimate the real-life optimum serum infliximab (sIFX) degree and set a medical threshold worth for a drug-tolerant ADA assay. Trough ranges of sIFX had been measured with ELISA. Free ADA was measured with two drug-sensitive strategies (ELISA and a bioassay) and one drug-tolerant methodology (PandA).
Two real-life cohorts handled with infliximab had been included; a cross-sectional cohort together with sufferers with inflammatory rheumatic ailments (n = 270) and a potential cohort of rheumatoid arthritis (RA) sufferers (n = 73) adopted for 1 yr.
Regular vary of sIFX was estimated from the possible cohort and an arbitrary optimum drug degree was set to be between 1 and 6 μg/mL. Utilizing this vary, optimum sIFX was present in solely 60% (163/270) of the sufferers within the cross-sectional cohort. These sufferers had considerably higher remedy response than these with a drug degree below 1 μg/mL, who had an ADA frequency of 34% (19/56) utilizing the drug-tolerant methodology.
Within the potential cohort, the drug-tolerant assay might establish 34% (53/155 samples) as ADA optimistic in samples with sIFX degree >0.2 μg/mL. ADA had been seldom detected in sufferers with >1 μg/mL sIFX, with three fascinating exceptions. A clinically related ADA threshold was decided to be >three RECL as measured with the drug-tolerant assay. In a real-life setting, there was a considerable variety of sufferers with suboptimal drug ranges and a proportion of those had ADA.
Each too low and too excessive drug ranges correlated with worse illness, however for various causes. Including a drug-tolerant assay enabled detection of ADA earlier and no matter drug degree at time of sampling.
MOUSE ANTI HUMAN TNF ALPHA |
|||
| MBS213345-02mg | MyBiosource | 0.2mg | EUR 935 |
MOUSE ANTI HUMAN TNF ALPHA |
|||
| MBS213345-5x02mg | MyBiosource | 5x0.2mg | EUR 4045 |
Tumor necrosis factor alpha TNF-? (72 - 82), human (AA: Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg) (MW: 1171.33) |
|||
| SP-86635-5 | Alpha Diagnostics | 5 mg | EUR 343.2 |
Monoclonal Anti-Human Tumor Necrosis Factor-Alpha (TNF-alpha) IgG #1 aff. Pure |
|||
| TNFA11-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
Monoclonal Anti-Human Tumor Necrosis Factor-Alpha (TNF-alpha) IgG #2, aff. Pure |
|||
| TNFA12-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
Alpha 2-Antiplasmin, Human Plasma |
|||
| A2AP15-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Alpha 1-Antitrypsin, Human Plasma |
|||
| A1AT15-N | Alpha Diagnostics | 1 mg | EUR 196.8 |
Recombinant (E.Coli) Human p38 alpha/SAPK2 alpha |
|||
| RP-675 | Alpha Diagnostics | 1 ug | EUR 343.2 |
Rabbit Anti-Rat TNF-alpha Converting Enzyme (TACE) antiserum |
|||
| TACE11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Alpha 1-Antichymotrypsin , Human Plasma |
|||
| A1CT15-N-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Rabbit Anti-Human alpha-Tubulin IgG |
|||
| TUBA13-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Goat Anti-Human Tumor Necrosis Factor-Alpha (TNF-alpha) IgG #2, aff. Pure (neutralzing) |
|||
| TNFA13-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Pig Tumor Necrosis Factor Alpha (TNF-a) ELISA Kit, 96 tests, Quantitative |
|||
| 9965 | Alpha Diagnostics | 1 Kit | EUR 927.6 |
Recombinant (E.Coli) purified human Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
|||
| TNFA15-R-10 | Alpha Diagnostics | 10 ug | EUR 270 |
Monoclonal Anti-Human alpha-Tubulin IgG |
|||
| TUBA12-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Rabbit Anti-human Topoisomerase II alpha (TOP2 alpha) IgG, aff pure |
|||
| TOP2A11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Canine Tumor Necrosis Factor alpha (TNF-a) ELISA Kit, 96 tests, Quantitative |
|||
| 10460 | Alpha Diagnostics | 1 Kit | EUR 927.6 |
Bovine Tumor necrosis factor alpha (TNF-A) ELISA Kit, 96 tests, Quantitative |
|||
| 9810 | Alpha Diagnostics | 1 Kit | EUR 927.6 |
Chicken Anti-Human alpha 1 anti-trypsin IgG/Y |
|||
| A1AT12-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Tumor necrosis factor alpha TNF-? (78-96) (human) (AA: His-Thr-Ile-Ser-Arg-Ile-Ala-Val-Ser-Tyr-Gln-Thr-Lys-Val-Asn-Leu-Leu-Ser-Ala) (MW: 2101.45) |
|||
| SP-89730-1 | Alpha Diagnostics | 1 mg | EUR 196.8 |
Rabbit Anti-Human p73 alpha antiserum # 2 |
|||
| P73A12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Tumor necrosis factor alpha TNF-? (46-65) (human) (AA: Asn-Gln-Leu-Val-Val-Pro-Ser-Glu-Gly-Leu-Tyr-Leu-Ile-Tyr-Ser-Gln-Val-Leu-Phe-Lys) (MW: 2310.74) |
|||
| SP-89728-1 | Alpha Diagnostics | 1 mg | EUR 489.6 |
Rabbit Anti-Human Glutathione Transferase alpha (GST-alpha) antiserum |
|||
| GSTA12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Guinea pig Tumor Necrosis Factor Alpha (TNF-a) ELISA Kit, 96 tests, Quantitative |
|||
| 9870 | Alpha Diagnostics | 1 Kit | EUR 927.6 |
Tumor necrosis factor alpha TNF-? (31 - 45), human (AA: Arg-Arg-Ala-Asn-Ala-Leu-Leu-Ala-Asn-Gly-Val-Glu-Leu-Arg-Asp) (MW: 1667.90) |
|||
| SP-86636-1 | Alpha Diagnostics | 1 mg | EUR 196.8 |
Human Alpha-Thrombin (human plasma), purified |
|||
| TBNA16-N-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
human Topoisomerase II alpha (TOP2 alpha) Control/blocking peptide |
|||
| TOP2A11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Recombinant Human Alpha-Synuclein |
|||
| RP-847 | Alpha Diagnostics | 20 ug | EUR 196.8 |
Rabbit Anti-Human Estrogen receptor alpha (ER-alpha) peptide IgG |
|||
| ERA12-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-Human p73 alpha/beta antiserum # 1 |
|||
| P73A11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Recombinant purified human TNF Receptor 2 (TNFR2/TNF-RII, Etannercept/TNF-R75, p75TNFR) protein (E.Coli, His-tag) |
|||
| TNFR25-R-20 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Recombinant purified, human Interleukin-1 alpha (IL-1 alpha), active |
|||
| IL1A15-R-10 | Alpha Diagnostics | 10 ug | EUR 416.4 |
Monoclonal anti-human Alpha (FSH-Alpha), IgG clone 3 aff pure |
|||
| FSHA12-M | Alpha Diagnostics | 1 mg | EUR 578.4 |
Goat Anti-human Alpha fetoprotein (AFP) IgG, pure |
|||
| AFP13-A | Alpha Diagnostics | 1 mg | EUR 781.2 |
Goat Anti-Human Lutenizing Hormone Alpha (LH-Alpha) IgG aff pure |
|||
| LHA13-A | Alpha Diagnostics | 1 mg | EUR 343.2 |
Tumor necrosis factor alpha TNF-? (10-36) (human) (AA: Asp-Lys-Pro-Val-Ala-His-Val-Val-Ala-Asn-Pro-Gln-Ala-Glu-Gly-Gln-Leu-Gln-Trp-Leu-Asn-Arg-Arg-Ala-Asn-Ala-Leu) (MW: 2996.41) |
|||
| SP-89727-1 | Alpha Diagnostics | 1 mg | EUR 270 |
Rabbit Anti-Rat TNF-alpha Converting Enzyme (TACE), IgG aff. Pure |
|||
| TACE11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Goat Anti-human Chorionic Gonadotropin Alpha (hCG-Alpha) IgG aff pure |
|||
| HCGA13-A | Alpha Diagnostics | 1 mg | EUR 343.2 |
Rabbit Anti-Human HE2 alpha IgG #1, aff pure |
|||
| HE2A11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-Human p73 alpha/ IgG # 2, aff pure |
|||
| P73A12-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-Human alpha-Tubulin IgG-HRP Conjugate |
|||
| TUBA13-HRP | Alpha Diagnostics | 100 ul | EUR 518.4 |
Recombinant (E.Coli) Human Thyrostimulin Alpha |
|||
| RP-595 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Rabbit Anti-Human alpha-Tubulin IgG-Biotin Conjugate |
|||
| TUBA13-BTN | Alpha Diagnostics | 100 ul | EUR 562.8 |
Alpha 1-Antitrypsin (A1AT), Human protein control for WB |
|||
| A1AT11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Alpha 2-HS Glycoprotein, Human Plasma |
|||
| A2HG15-N | Alpha Diagnostics | 1 mg | EUR 343.2 |
Alpha 2-Macroglobulin (A2M), Human Plasma |
|||
| A2MG15-N | Alpha Diagnostics | 1 mg | EUR 196.8 |
Goat Anti-Human Alpha 1-Antitrypsin (A1AT) IgG, unlabeled |
|||
| A1AT11-A | Alpha Diagnostics | 100 ul | EUR 489.6 |
Rabbit Anti-Human Resistin-Like protein alpha (RELM-alpha/FIZZ1) antiserum #2 |
|||
| RELMA12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Chicken Anti-Human Alpha 2 Macroglobulin (A2M) IgG/Y |
|||
| A2MG13-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Recombinant (E.Coli) Human Crystallin Alpha A |
|||
| RP-611 | Alpha Diagnostics | 20 ug | EUR 196.8 |
Recombinant (E.Coli) Human Crystallin Alpha B |
|||
| RP-612 | Alpha Diagnostics | 20 ug | EUR 196.8 |
Human Alpha Feto Protein (AFP) High Pure |
|||
| AFP15-N | Alpha Diagnostics | 1 mg | EUR 854.4 |
Monoclonal Anti-Human Chorionic Gonadotropin Alpha (hCG-alpha) IgG #1, aff pure |
|||
| HCGA11-M | Alpha Diagnostics | 1 mg | EUR 343.2 |
HUMAN ANTI TNF ALPHA (INFLIXIMAB BIOSIMILAR) |
|||
| MBS226034-02mg | MyBiosource | 0.2mg | EUR 715 |
HUMAN ANTI TNF ALPHA (INFLIXIMAB BIOSIMILAR) |
|||
| MBS226034-5x02mg | MyBiosource | 5x0.2mg | EUR 3045 |
Rabbit Anti-Human p73 alpha/beta IgG # 1, aff pure |
|||
| P73A11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Anti-Human TNF alpha |
|||
| GWB-8F48ED | GenWay Biotech | 1 mL | Ask for price |
Anti-Human TNF-&alpha |
|||
| GWB-BIG93C | GenWay Biotech | 500ug | Ask for price |
Anti-Human TNF alpha |
|||
| GWB-619378 | GenWay Biotech | 1 mg | Ask for price |
Monoclonal Anti-human Chronionic Gonadotropin Alpha (hCG-Alpha) IgG #2, caff pure |
|||
| HCGA12-M | Alpha Diagnostics | 1 mg | EUR 343.2 |
Mouse Monoclonal Anti-human Alpha fetoprotein (AFP) (clone 1) |
|||
| AFP11-M | Alpha Diagnostics | 1 mg | EUR 578.4 |
Mouse Monoclonal Anti-human Alpha fetoprotein (AFP) (clone 2) |
|||
| AFP12-M | Alpha Diagnostics | 1 mg | EUR 578.4 |
Recombinant (E.Coli) Human Estrogen Receptor Alpha |
|||
| RP-940 | Alpha Diagnostics | 2 ug | EUR 416.4 |
Human Alpha Synuclein (A30P) Recombinant protein |
|||
| SYN-A30P-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Human Alpha Synuclein (A53T) Recombinant protein |
|||
| SYN-A53T-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Rabbit Anti-Human Alpha Defensin 4 (NP-4) antiserum #1 |
|||
| HDEFA41-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-Human Alpha Defensin 5 (NP-5),antiserum #1 |
|||
| HDEFA51-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-Human Alpha Defensin 6 (NP-6) antiserum #1 |
|||
| HDEFA61-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Recombinant (E.Coli) purified human Tumor Necrosis Factor-Alpha Variant (TNF-alpha variant, 151-aa), biologically active |
|||
| TNFA16-R-10 | Alpha Diagnostics | 10 ug | EUR 270 |
Human HE2 alpha Control/blocking peptide #1 |
|||
| HE2A11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Human p73 alpha Control/blocking peptide #2 |
|||
| P73A12-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Sheep Anti-Human alpha 1 antichymotrypsin (ACT) IgG, aff pure |
|||
| ACT11-A | Alpha Diagnostics | 100 ug | EUR 489.6 |
Rabbit Anti-Human GABAa Receptor alpha 1 (GAA1) Antiserum #1 |
|||
| GAA11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Monoclonal anti-human Lutenizing Hormone Alpha (LH-Alpha) IgG, clone 2 aff pure |
|||
| LHA12-M | Alpha Diagnostics | 1 mg | EUR 343.2 |
Goat Anti-Human Alpha 1-Antitrypsin (A1AT) IgG, HRP conjugate |
|||
| A1AT11-HRP | Alpha Diagnostics | 100 ul | EUR 489.6 |
Recombinant (E.Coli) Human Casein Kinase 2 alpha |
|||
| RP-666 | Alpha Diagnostics | 3 ug | EUR 708 |
Recombinant (Sf9) Human Protein Kinase C alpha |
|||
| RP-676 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Goat Anti-Human IgA (alpha chain sp.) IgG-Biotin Conjugate |
|||
| 10040 | Alpha Diagnostics | 0.5 mg | EUR 242.4 |
Goat Anti-Ferret IgA (alpha), unlabeled |
|||
| 70519 | Alpha Diagnostics | 0.5 mg | EUR 255.6 |
Goat Anti-Human Alpha 1-Antitrypsin (A1AT) IgG, Biotin conjugate |
|||
| A1AT11-BT | Alpha Diagnostics | 100 ul | EUR 489.6 |
Purified Human alpha 1 antichymotrypsin (ACT) protein control for WB |
|||
| ACT11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Monoclonal Anti-Human alpha 1 antichymotrypsin (ACT) IgG, aff pure |
|||
| ACT12-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-Human Core-binding factor alpha (CBFA1) antiserum #1 |
|||
| CBFA11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Recombinant (E.Coli) Human Retinoid X Receptor Alpha |
|||
| RP-1588 | Alpha Diagnostics | 10 ug | EUR 270 |
Rabbit Anti-Rat Glutathione Transferase alpha (GST-alpha) antiserum |
|||
| GSTA11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Human alpha 1 antichymotrypsin (ACT) (binds PSA to form PSA-ACT) >90% |
|||
| ACT15-N-100 | Alpha Diagnostics | 100 ug | EUR 315.6 |
Recombinant (P. Pastoris) Human collagen alpha-III |
|||
| RP-920 | Alpha Diagnostics | 10 mg | EUR 634.8 |
Rabbit Anti-Human GABAa Receptor alpha 1 (166-269aa) IgG #1, aff pure |
|||
| GAA14-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Human Alpha 1-Microglobulin A1M) High Pure (>98%) |
|||
| A1M15-N-100 | Alpha Diagnostics | 100 ug | EUR 270 |
Recombinant (E.Coli) Human Protein Phosphatase 2C alpha |
|||
| RP-680 | Alpha Diagnostics | 10 ug | EUR 270 |
Rabbit Anti-Human Resistin-Like protein alpha (RELM-alpha/FIZZ1) IgG #2, aff. Pure |
|||
| RELMA12-A | Alpha Diagnostics | 100 ug | EUR 578.4 |